Brooke LeVasseur is the CEO of AristaMD and has 20 years of leadership experience launching new, innovative healthcare products and solutions to payers and providers, including software and eConsult solutions. As an established entrepreneur and an innovative leader, Brooke has deep experience identifying, developing and launching new business offerings while managing teams to achieve operational goals. Her expertise spans the healthcare spectrum, from consumer health to devices and diagnostics.
Brooke has led teams to successfully commercialize new, innovative healthcare tools and gain widespread clinician adoption and reimbursement. She has held executive roles at Thomson Reuters, Veracyte and Sequenom, as well as an array of consultant roles at industry-leading investment and healthcare companies such as Kleiner Perkins Caufield & Byers, Versant Ventures, Illumina, Cypher Genomics and GRAIL.